Generative AI in Drug Discovery Market
According to Intent Market Research, the Generative AI in Drug Discovery Market is expected to grow from USD 1.3 billion in 2024-e at a CAGR of 37.6% to touch USD 12.1 billion by 2030. The Generative AI in Drug Discovery Market is dominated by key players such as IBM Corporation, Atomwise, BenevolentAI, Insilico Medicine, Exscientia, Recursion Pharmaceuticals, Healx, Exscientia, Moderna, Schrodinger, Biogen, Novartis, GSK, Pfizer, Eli Lilly.